Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks
Public ClinicalTrials.gov record NCT05419505. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
APHRODITE-1: A Phase 2, Open Label, Self-Controlled Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks in Adult Females
Study identification
- NCT ID
- NCT05419505
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Interventions
- CCH-aaes Drug
- Antifibrinolytic Agent Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 14, 2022
- Primary completion
- Jan 2, 2023
- Completion
- Jun 20, 2023
- Last update posted
- Mar 6, 2025
2022 – 2023
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Clinical Trial Site #6 | Scottsdale | Arizona | 85255 | — |
| Endo Clinical Trial Site #4 | Beverly Hills | California | 90210 | — |
| Endo Clinical Trial Site #9 | Encinitas | California | 92024 | — |
| Endo Clinical Trial Site #10 | San Diego | California | 92121 | — |
| Endo Clinical Trial Site #7 | Solana Beach | California | 92075 | — |
| Endo Clinical Trial Site #12 | Greenwood Village | Colorado | 80111 | — |
| Endo Clinical Trial Site #8 | Coral Gables | Florida | 33146 | — |
| Endo Clinical Trial Site #13 | Miami | Florida | 33137 | — |
| Endo Clinical Trial Site #3 | Chicago | Illinois | 60611 | — |
| Endo Clinical Trial Site #2 | Metairie | Louisiana | 700006 | — |
| Endo Clinical Trial Site #11 | New York | New York | 10021 | — |
| Endo Clinical Trial Site #1 | Nashville | Tennessee | 37215 | — |
| Endo Clinical Trial Site #5 | Pflugerville | Texas | 78660 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05419505, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05419505 live on ClinicalTrials.gov.